Nephrol Dial Transplant (2000) 15: 1379-1383
© 2000 European Renal Association-European Dialysis and Transplant Association
Urinary excretion of podocytes in patients with diabetic nephropathy
1 Department of Medicine, Misato Junshin Hospital, Saitama, 2 Department of Pediatrics, Yoshida Hospital, Niigata and 3 Department of Medicine, Koto Hospital, Tokyo, Japan
Background. Detection of podocytes in the urinary sediments of children with glomerulonephritis has been shown to indicate severe injury to the podocytes. The aim of the present study was to determine whether podocytes are present in the urine sediments of adult patients with diabetes with and without nephropathy and whether trandolapril is effective for podocyte injury.
Methods. Fifty diabetic patients (10 with normoalbuminuria, 15 with microalbuminuria, 15 with macroalbuminuria and 10 with chronic renal failure) and 10 healthy controls were studied. Urinary podocytes were examined by immunofluorescence using monoclonal antibodies against podocalyxin, which is present on the surface of podocytes. In addition, we studied plasma metalloproteinase (MMP)-9 concentrations in all patients.
Results. Urinary podocytes were absent in healthy controls, diabetic patients with normoalbuminuria and diabetic patients with chronic renal failure. Podocytes were detected in the urine of eight diabetic patients with microalbuminuria (53%) and of 12 patients with macroalbuminuria (80%). The number of podocytes in the urine of patients with macroalbuminuria was significantly greater than in patients with microalbuminuria (P<0.01). However, there was no relationship between urinary albumin excretion and urinary podocytes. In addition, plasma MMP-9 concentrations were significantly correlated with the number of urinary podocytes (P<0.01). Twelve diabetic patients with macroalbuminuria and eight patients with microalbuminuria who had urinary podocytes were treated with the angiotensin-converting enzyme inhibitor trandolapril. Urinary albumin excretion, the number of podocytes and plasma MMP-9 concentrations were reduced by the trandolapril treatment.
Conclusions. Podocytes in the urine may be a useful marker of disease activity in diabetic nephropathy. Trandolapril may be effective for podocyte injury.
Keywords: basement membrane; epithelial cell; extracellular matrix; glomerulosclerosis; microalbuminuria; podocalyxin
Correspondence and offprint requests to: Hikaru Koide, MD, Department of Medicine, Koto Hospital, 6-8-5 Ojima, Koto-ku, Tokyo 136-0072, Japan.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Zhao, X. Gu, L. J. Groome, and Y. Wang Decreased Nephrin and GLEPP-1, But Increased VEGF, Flt-1, and Nitrotyrosine, Expressions in Kidney Tissue Sections From Women With Preeclampsia Reproductive Sciences, October 1, 2009; 16(10): 970 - 979. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Sato, B. L. Wharram, S. K. Lee, L. Wickman, M. Goyal, M. Venkatareddy, J. W. Chang, J. E. Wiggins, C. Lienczewski, M. Kretzler, et al. Urine Podocyte mRNAs Mark Progression of Renal Disease J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1041 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Sussman, T. Sun, R. M. Krofft, and R. V. Durvasula SPARC Accelerates Disease Progression in Experimental Crescentic Glomerulonephritis Am. J. Pathol., May 1, 2009; 174(5): 1827 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Cormack-Aboud, P. T. Brinkkoetter, J. W. Pippin, S. J. Shankland, and R. V. Durvasula Rosuvastatin protects against podocyte apoptosis in vitro Nephrol. Dial. Transplant., February 1, 2009; 24(2): 404 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Skoberne, A. Konieczny, and M. Schiffer Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol, February 1, 2009; 296(2): F230 - F241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Spurney and T. M. Coffman Stressed-out Podocytes in Diabetes? J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2035 - 2037. [Full Text] [PDF]
|
|
|
|
|
|
C. Ruster, T. Bondeva, S. Franke, M. Forster, and G. Wolf Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2179 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mima, H. Arai, T. Matsubara, H. Abe, K. Nagai, Y. Tamura, K. Torikoshi, M. Araki, H. Kanamori, T. Takahashi, et al. Urinary Smad1 Is a Novel Marker to Predict Later Onset of Mesangial Matrix Expansion in Diabetic Nephropathy Diabetes, June 1, 2008; 57(6): 1712 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Granier, K. Makni, L. Molina, B. Jardin-Watelet, H. Ayadi, and F. Jarraya Gene and protein markers of diabetic nephropathy Nephrol. Dial. Transplant., March 1, 2008; 23(3): 792 - 799. [Full Text] [PDF]
|
|
|
|
|
|
L. De Petris, K. A. Hruska, S. Chiechio, and H. Liapis Bone morphogenetic protein-7 delays podocyte injury due to high glucose Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3442 - 3450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Toyoda, B. Najafian, Y. Kim, M. L. Caramori, and M. Mauer Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy Diabetes, August 1, 2007; 56(8): 2155 - 2160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Gilbert, S. A. Kim, K. R. Tuttle, G. L. Bakris, R. D. Toto, J. B. McGill, D. J. Haney, D. J. Kelly, and P. W. Anderson Effect of Ruboxistaurin on Urinary Transforming Growth Factor-{beta} in Patients With Diabetic Nephropathy and Type 2 Diabetes Diabetes Care, April 1, 2007; 30(4): 995 - 996. [Full Text] [PDF]
|
|
|
|
|
|
C. Friedrich, N. Endlich, W. Kriz, and K. Endlich Podocytes are sensitive to fluid shear stress in vitro Am J Physiol Renal Physiol, October 1, 2006; 291(4): F856 - F865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Macconi, M. Bonomelli, A. Benigni, T. Plati, F. Sangalli, L. Longaretti, S. Conti, H. Kawachi, P. Hill, G. Remuzzi, et al. Pathophysiologic Implications of Reduced Podocyte Number in a Rat Model of Progressive Glomerular Injury Am. J. Pathol., January 1, 2006; 168(1): 42 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Pedchenko, S. V. Chetyrkin, P. Chuang, A.-J. L. Ham, M. A. Saleem, P. W. Mathieson, B. G. Hudson, and P. A. Voziyan Mechanism of Perturbation of Integrin-Mediated Cell-Matrix Interactions by Reactive Carbonyl Compounds and Its Implication for Pathogenesis of Diabetic Nephropathy Diabetes, October 1, 2005; 54(10): 2952 - 2960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wolf, S. Chen, and F. N. Ziyadeh From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease: Podocyte Injury Comes of Age in Diabetic Nephropathy Diabetes, June 1, 2005; 54(6): 1626 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hara, T. Yanagihara, I. Kihara, K. Higashi, K. Fujimoto, and T. Kajita Apical Cell Membranes Are Shed into Urine from Injured Podocytes: A Novel Phenomenon of Podocyte Injury J. Am. Soc. Nephrol., February 1, 2005; 16(2): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Patari, C. Forsblom, M. Havana, H. Taipale, P.-H. Groop, and H. Holthofer Nephrinuria in Diabetic Nephropathy of Type 1 Diabetes Diabetes, December 1, 2003; 52(12): 2969 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lods, P. Ferrari, F. J. Frey, A. Kappeler, C. Berthier, B. Vogt, and H.-P. Marti Angiotensin-Converting Enzyme Inhibition but not Angiotensin II Receptor Blockade Regulates Matrix Metalloproteinase Activity in Patients with Glomerulonephritis J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2861 - 2872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. U. Vogelmann, W. J. Nelson, B. D. Myers, and K. V. Lemley Urinary excretion of viable podocytes in health and renal disease Am J Physiol Renal Physiol, July 1, 2003; 285(1): F40 - F48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guo, P. W. Sanders, A. Woods, and C. Wu The Distribution and Regulation of Integrin-Linked Kinase in Normal and Diabetic Kidneys Am. J. Pathol., November 1, 2001; 159(5): 1735 - 1742. [Abstract] [Full Text] [PDF]
|
|